BioLife Solutions BLFS
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$5.60M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 40.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 5.85% to 8.17% of float over the last 6 biweekly reports (15 Jul 2026 to 30 Sep 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Glazer Capital, LLC | Hedge Fund | 2026/Q3 | +2,685,520 | 5.5% |
| Axiom Investors LLC | Mutual Fund | 2026/Q3 | +171,590 | 0.4% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +625,658 | 1.3% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +574,158 | 1.9% |
| Roubaix Capital, LLC | Hedge Fund | 2026/Q3 | +309,618 | 0.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +273,780 | 13.0% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +235,314 | 0.8% |
| Thrivent Investment Management, Inc. | Mutual Fund | 2026/Q3 | +213,744 | 0.5% |
| Next Century Growth Investors LLC | Mutual Fund | 2026/Q3 | +196,889 | 1.1% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +183,061 | 0.4% |
| Diamond Hill Capital Management, LLC | Mutual Fund | 2026/Q3 | +153,887 | 0.3% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +132,942 | 0.3% |
| Susquehanna International Group, LLP | Private Company | 2026/Q3 | +127,996 | 0.3% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +114,938 | 2.2% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +78,851 | 3.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 17 Sep 2026 | Roderick de Greef | Director | Sale to Issuer | -2,775 | $36.69 | 415,552 |
| 17 Sep 2026 | Aby Mathew | Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer | Sale to Issuer | -564 | $36.69 | 387,269 |
| 17 Sep 2026 | Todd Berard | Chief Marketing Officer | Sale to Issuer | -470 | $36.69 | 161,823 |
| 17 Sep 2026 | Troy Wichterman | Chief Financial Officer | Sale to Issuer | -937 | $36.69 | 211,286 |
| 17 Sep 2026 | Sean Werner | Chief Technology Officer | Sale to Issuer | -421 | $36.69 | 47,135 |
| 7 Sep 2026 | Aby Mathew | Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer | Sale to Issuer | -627 | $35.38 | 387,833 |
| 7 Sep 2026 | Todd Berard | Chief Marketing Officer | Sale to Issuer | -356 | $35.38 | 162,293 |
| 7 Sep 2026 | Troy Wichterman | Chief Financial Officer | Sale to Issuer | -1,026 | $35.38 | 212,223 |
| 16 Jul 2026 | Sean Werner | Chief Technology Officer | Sale to Issuer | -275 | $29.15 | 47,556 |
| 6 Jul 2026 | Aby Mathew | Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer | Sale to Issuer | -516 | $27.79 | 388,460 |
| 6 Jul 2026 | Todd Berard | Chief Marketing Officer | Sale to Issuer | -293 | $27.79 | 162,649 |
| 6 Jul 2026 | Troy Wichterman | Chief Financial Officer | Sale to Issuer | -844 | $27.79 | 213,249 |
| 17 Jun 2026 | Roderick de Greef | Director | Sale to Issuer | -2,775 | $26.04 | 386,596 |
| 17 Jun 2026 | Aby Mathew | Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer | Sale to Issuer | -564 | $26.04 | 388,976 |
| 17 Jun 2026 | Todd Berard | Chief Marketing Officer | Sale to Issuer | -470 | $26.04 | 162,942 |
| 17 Jun 2026 | Troy Wichterman | Chief Financial Officer | Sale to Issuer | -937 | $26.04 | 214,093 |
| 17 Jun 2026 | Sean Werner | Chief Technology Officer | Sale to Issuer | -420 | $26.04 | 47,831 |
| 7 Jun 2026 | Aby Mathew | Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer | Sale to Issuer | -627 | $26.10 | 389,540 |
| 7 Jun 2026 | Todd Berard | Chief Marketing Officer | Sale to Issuer | -356 | $26.10 | 163,412 |
| 7 Jun 2026 | Troy Wichterman | Chief Financial Officer | Sale to Issuer | -1,026 | $26.10 | 215,030 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Sep 2026 | 3,999,252 | 8.2% | 4.3 |
| 15 Sep 2026 | 3,884,193 | 7.9% | 4.5 |
| 31 Aug 2026 | 3,925,949 | 8.0% | 4.8 |
| 14 Aug 2026 | 4,017,528 | 8.2% | 7.8 |
| 31 Jul 2026 | 4,544,348 | 9.3% | 2.1 |
| 15 Jul 2026 | 2,856,425 | 5.8% | 5.0 |
No comments yet — be the first to weigh in on BLFS.
Sign in to join the discussion.